Alida L P Caforio, MD, PhD, FESC is an expert in Cardiology at Azienda Ospedaliera di Padova (Italy). As of October 2026, ScienceLeadR ranks Alida L P Caforio in the top 1% of experts worldwide for Myocarditis, Cardiomegaly and Cardiomyopathies. Alida L P Caforio has authored 285 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 1,164 (community average: 125). How the SLR is computed.

LeadR Profile

Alida L P Caforio, MD, PhD, FESC Azienda Ospedaliera di Padova Italy
1 164 ScienceLeadR Reputation 1164
Network Map

Cardiology

Subspecialties: Public Health - Immunology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026

Source: PubMed

University of Padua

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 285

Citations

Citations: 30 015 1st author: 75 Last author: 50 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Early Introduction and Prolonged Full-Dose Anakinra Reduce Recurrence Risk After Discontinuation in Recurrent Pericarditis: An International Multicenter Cohort.
PMID 42885757 — heart diseases, pharmaceutical preparations, duration of therapy, pericarditis, maintenance, therapeutics
J Am Heart Assoc20260
Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society.
PMID 42669046 — heart failure, heart, arrhythmias, cardiac, cold temperature, cardiology, myocarditis, therapeutics, cardiomyopathies
Europace20260
Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society.
PMID 42663246 — heart failure, heart, arrhythmias, cardiac, cold temperature, cardiology, myocarditis, therapeutics, cardiomyopathies
Eur J Heart Fail20260
Cardiac Troponin in Autoimmune Rheumatic Diseases: Lights and Shadows.
PMID 42537983 — fibrosis, troponin, biomarkers, rheumatic diseases, scleroderma, systemic
Mayo Clin Proc20260
Risk prediction of death and heart transplantation in adult patients with myocarditis.
PMID 42358807 — cells, antibodies, heart, biopsy, myocarditis, heart transplantation, diagnosis, transplantation
Eur Heart J Open20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 2
N/A 1
Phase 2/Phase 3 1

By status:

Recruiting 2
Completed 1
Unknown 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy
2025-522553-19-00 — exercise, cardiomyopathy, dilated, safety, cardiomyopathies
Phase 2/Phase 3Recruiting2026
CardiolRx in Recurrent Pericarditis (MAVERIC Phase 3)
NCT06708299 — syringes, pericarditis, food, interleukin-1, cannabidiol
Phase 3Recruiting2025

LeadR Networks

Main global connection map